Inspired: WCG partners with health care social network to bolster clinical trial recruitment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/cofotoisme)
(Image: Getty/cofotoisme)
WCG is partnering with Inspire, an online community of patients and caregivers, to connect research sponsors with potential clinical trial participants.

The WIRB-Copernicus Group’s (WCG) ​Clinical Services Division yesterday announced its partnership with Inspire, which has 1.5m members and 10m active annual users across 225 individual communities representing more than 3,600 discrete medical conditions. The news comes on the heels of a partnership with InformedDNA​ to support clinical trials using genetics.

“WCG and Inspire both recognize the critical role that patients play in advancing medical progress,”​ said Donald A. Deieso, PhD, executive chairman and chief executive officer, WCG.

Through its partnership with Inspire, Deieso said it is “making it easier for patients to access cutting-edge treatments by helping them identify relevant clinical trial opportunities.” ​Additionally, he noted that it also will make it easier for researchers to locate hard-to-find patients interested in participating in research.

“By adding Inspire to WCG’s already robust patient engagement platform, we’re enabling research sponsors to connect directly and more effectively with potential research volunteers, making clinical trials more patient-centric and ultimately accelerating the development of life-changing therapies to the patients who need them,”​ Deieso told us.

The companies will use permission-based and opt-in approaches to connect patients with clinical trial opportunities. As the Inspire network grows – membership to which is open to patients, caregivers, and providers across all therapeutic areas – Dieso said the company has an opportunity to serve each community, among new ones.

“WCG has a number of resources to share with Inspire community members, including the guidance of genetic specialists and counselors through our partnership with InformedDNA,”​ he said. “WCG and Inspire are committed to empowering patients by giving them greater access to educational resources and clinical trial opportunities.”

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars